Treatment Preference in Patients with NMOSD

Not Applicable

Recruiting

• Conditions: NMOSD; D009471; euromyelitis Optica Spectrum Disorders

• Registration Number: JPRN-jRCT1030230308
• Lead Sponsor: Yamashita Katsuhisa

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2023-08-25
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: 30

Inclusion Criteria

Subjects who meet all of the following criteria:
(1)Documented diagnosis of NMOSD
(2)Anti-aquaporin-4 antibody test positive
(3)Patients who are taking or have taken an oral steroid
(4)Patients aged 20 years or older at the time of enrollment
(5)Must have sufficient understanding to conduct the research (The patient may require assistance in reading aloud, etc. due to visual disturbance.)
(6)Individuals who have consented to participate in this research
(7)Patients who are living in Japan at the time of enrollment
(8)Individuals who have equipment/communication environment to apply for research participation online and perform interviews or respond to questionnaires

Exclusion Criteria

Subjects who meet any of the following criteria:
(1)Patients who have difficulty in obtaining consent or conducting this research due to a lack of Japanese ability
(2)Patietnts who cannot participate in the survey

Study & Design

• Study Type: Other
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
causal Relationship between Subjective Adverse Event Experience and Impact on Daily Living of Patients with NMOSD

Secondary Outcome Measures

Name	Time	Method
subjective Adverse Event Experience and Importance of Impact on Daily Living of Patients with NMOSD